Author

Kana Fujimoto

Institution: Kishiwada City Hospital

Observed institution: Kishiwada City Hospital

ORCID: 0000-0003-0376-3962

Observed ORCID: 0000-0003-0376-3962

OpenAlex ID: A5032956529

Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants

2022 · Kana Fujimoto, Satoru Mutsuo, et al. · Infectious Disease Reports · 5

Successful treatment with atezolizumab combination chemotherapy in a patient with high‐grade fetal adenocarcinoma of the lung: A case report

2022 · Kana Fujimoto, Satomi Watanabe, et al. · Thoracic Cancer · 4

Tolerability and effectiveness of definitive chemoradiotherapy in locally advanced lung cancer patients with combined pulmonary fibrosis and emphysema

2026 · Kana Fujimoto, Mariko Kogo, et al. · Cancer Treatment and Research Communications

Works count: 3

Citation count: 9

H-index: 2

I10-index: